Drug Transport & Delivery, Dpt. Physics, Chemistry & Pharmacy, University of Southern Denmark, Odense DK-5230, Denmark.
AbbVie Deutschland GmbH & Co. KG, Ludwigshafen D-67061, Germany.
Eur J Pharm Sci. 2020 Nov 1;154:105497. doi: 10.1016/j.ejps.2020.105497. Epub 2020 Jul 29.
The dispersive behavior of three different amorphous solid dispersion (ASD) formulations of the poorly soluble ABT-199 (Venetoclax) were studied in aqueous and biomimetic media and spontaneously forming supramolecular associates and particles analysed. To this end, the aqueous dispersions were fractionated into a submicron (colloidal) and micrometer-sized particle-fraction by bench-top centrifugation. The submicron fraction was characterized by Asymmetric Flow Field-Flow Fractionation in conjunction with Multi-angle Laser Light Scattering (AF4-MALLS), Dynamic Light Scattering (DLS) and zeta potential analysis. The micron particle fraction was characterized by Single Particle Optical Sensing (SPOS) and light microscopy. Furthermore, drug contents were monitored in terms of total dispersed drug and apparently dissolved drug in the submicron fraction. Despite the fact, that all three formulations showed decent dispersive behavior with almost the complete drug content rapidly dispersed, substantial differences were identified between two of the formulations and the third one: ABT-199/12 and ABT-199/20 showed pronounced precipitation of the drug in form of micrometer particles, a phenomenon described as glass liquid phase separation (GLPS) and only a marginal fraction of the drug was found in the submicron-fraction, i.e. associated with 3 to 4 different supramolecular assemblies (micelles), irrespective whether buffer or fasted state simulated intestinal fluid (FaSSIF) were used as dispersion media. In contrast, ABT-199/40 showed pronounced formation of a wide variety of supramolecular assemblies (micelles) along with substantial association of the drug with all of these, but reduced glass liquid phase separation.
研究了三种不同的不溶性 ABT-199(Venetoclax)无定形固体分散体(ASD)配方在水相和仿生介质中的分散行为,并分析了自发形成的超分子缔合物和颗粒。为此,通过台式离心将水分散体分成亚微米(胶体)和微米级颗粒级分。通过不对称流场流分离与多角度激光光散射(AF4-MALLS)、动态光散射(DLS)和zeta 电位分析对亚微米级级分进行了表征。通过单颗粒光学感应(SPOS)和光学显微镜对微米颗粒级分进行了表征。此外,还监测了亚微米级级分中总分散药物和明显溶解药物的药物含量。尽管所有三种配方都表现出良好的分散行为,几乎完全快速分散了药物含量,但其中两种配方与第三种配方之间存在显著差异:ABT-199/12 和 ABT-199/20 表现出药物以微米颗粒形式明显沉淀的现象,称为玻璃液相分离(GLPS),只有一小部分药物存在于亚微米级级分中,即与 3 到 4 种不同的超分子组装体(胶束)相关联,无论使用缓冲液还是快速状态模拟肠液(FaSSIF)作为分散介质。相比之下,ABT-199/40 表现出各种超分子组装体(胶束)的明显形成,以及药物与所有这些组装体的大量结合,但玻璃液相分离减少。